Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MEDP · against 111 other Healthcare companies of similar size
Ranked #35 of 112 · scores higher than 68% of peers
Bars: peers in each 10-point band of the growth score14 peers with a growth score of 70–79, including MEDP · Click a bar to see the companies
Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | MEDP | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 113 reported | 24.7% | 9.2% | 82% | 33% | |
| Earnings per share growthHigher is better · 88 reported | 18.3% | 17.7% | 51% | 33% | |
| 3-year revenue growthHigher is better · 110 reported | 18.5% | 9.4% | 78% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 9.3B USD | 98 | 64 | |
| 2 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 2 | 21.4B USD | 97 | 67 | |
| 4 | 16.5B USD | 96 | 37 | |
| 4 | 14.5B USD | 96 | 30 | |
| 32 | 68.0B BRL (≈$12.2B) | 77 | 67 | |
| 33 | 871.6B INR (≈$10.5B) | 76 | 66 | |
| 34 | 13.9B EUR (≈$15.3B) | 75 | 78 | |
| 35 | 193.6B HKD (≈$24.8B) | 74 | 78 | |
| 35 | 18.5B USD | 74 | 62 | |
| 35 | 11.4B USD | 74 | 64 | |
| 38 | 177.2B HKD (≈$22.7B) | 71 | 73 | |
| 38 | 27.8B USD | 71 | 55 | |
| 40 | 73.2B SAR (≈$19.8B) | 70 | 56 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score